620616-24-2

Upstream product

• 620615-98-7 (3R,4R)-4-(benzyloxy)-3-{[(tert-butyl)dimethylsilyl]oxy}pentanoic acid 
• 620616-21-9 (3R,4R)-4-Benzyloxy-3-(tert-butyl-dimethyl-silanyloxy)-pentanal 
• 53346-05-7 (R)-2-benzyloxypropanal 
• 94-66-6 2-allylcyclohexan-1-one 
• 6126-55-2 (6RS)-6-allyl-1,4-dioxaspiro[4.5]decane 
• 620616-12-8 2-{[(1RS,2RS)-2-allyl-1-methylcyclohexyl]oxy}ethyl (3R,4R)-4-(benzyloxy)-3-{[(tert-butyl)dimethylsilyl]oxy}pentanoate 
• 620615-97-6 (4R,5R)-5-(benzyloxy)-4-{[(tert-butyl)dimethylsilyl]oxy}pent-1-ene 
• 89104-01-8 (2R,3R)-2-(benzyloxy)-5-hexen-3-ol 

Relevant academic research and scientific papers

Synthesis and conformational analysis of macrocyclic dilactones mimicking the pharmacophore of aplysiatoxin

A small number of macrocyclic dilactones of type 3, i.e., 9, 10, 11, and epi-11, comprising a 3,4-dihydroxypentanoic acid unit, the pharmacophore of aplysiatoxin, and a conformationally preorganized ω-hydroxynonanoic acid unit were synthesized. Conformati